Immune-Onc Therapeutics Receives $7,000,000 Series A Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f5898bb3-aee7-484e-a6f6-345e537fc6be
Date
9/7/2016
Company Name
Immune-Onc Therapeutics
Mailing Address
1059 East Meadow Cir. Palo Alto, CA 94303 USA
Company Description
Immune-Onc Therapeutics, Inc. is a newly established biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment.
Website
http://www.immune-onc.com
Transaction Type
Venture Equity
Transaction Amount
$7,000,000
Transaction Round
Series A
Proceeds Purposes
The financing will support discovery and development of novel antibodies with breakthrough potential in the area of cancer immunotherapy.
M&A Terms
Venture Investor
CLI Ventures